Literature DB >> 25370586

Intraluminal cell transplantation prevents growth and rupture in a model of rupture-prone saccular aneurysms.

Serge Marbacher1, Juhana Frösén2, Johan Marjamaa2, Andrey Anisimov2, Petri Honkanen2, Michael von Gunten2, Usama Abo-Ramadan2, Juha Hernesniemi2, Mika Niemelä2.   

Abstract

BACKGROUND AND
PURPOSE: Aneurysm occlusion by intraluminal thrombus formation is the desired effect of all endovascular treatments. Intraluminal thrombus may, however, recanalize and be absorbed, unless it is infiltrated by cells that turn it into fibrous tissue (neointima). Because ruptured aneurysm walls are characterized by loss of smooth muscle cells, we assessed the impact of mural cell loss on wall remodeling of thrombosed aneurysms and investigated whether neointima formation could be enhanced by direct transplantation of cells into the thrombus.
METHODS: Sidewall aneurysms were microsurgically created in rats (n=81). Certain aneurysms were decellularized. Thrombosis was induced using direct injection of a fibrin polymer into the aneurysm. CM-Dil-labeled smooth muscle cells were injected into 25 of 46 fibrin embolized aneurysms. Recanalization and aneurysm growth were monitored with magnetic resonance angiography. Endoscopy, optical projection tomography, histology, and immunohistochemistry were used to study the fate of transplanted cells, thrombus organization, and neointima formation.
RESULTS: Decellularized embolized aneurysms demonstrated higher angiographic recurrence compared with decellularized embolized aneurysms with transplanted cells (P=0.037). Local cell replacement at the time of thrombosis resulted in better histological neointima formation than both nondecellularized embolized aneurysms (P<0.001) and decellularized embolized aneurysms (P=0.002). Aneurysm growth and rupture were observed exclusively in decellularized embolized aneurysms.
CONCLUSIONS: Lack of smooth muscle cells in the aneurysm wall promotes wall degradation, aneurysm growth and rupture, even if the aneurysm is occluded by luminal thrombus. Transplantation of smooth muscle cells into the luminal thrombus can reduce this degenerative remodeling.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cell transplantation; degeneration; inflammation; intracranial aneurysm; myofibroblasts; smooth muscle cells; thrombosis

Mesh:

Year:  2014        PMID: 25370586     DOI: 10.1161/STROKEAHA.114.006600

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Autologous adipose-derived mesenchymal stem cells improve healing of coiled experimental saccular aneurysms: an angiographic and histopathological study.

Authors:  Aymeric Rouchaud; Waleed Brinjikji; Daying Dai; Yong-Hong Ding; Tina Gunderson; Dana Schroeder; Laurent Spelle; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2017-01-11       Impact factor: 5.836

Review 2.  Recurrence of endovascularly and microsurgically treated intracranial aneurysms-review of the putative role of aneurysm wall biology.

Authors:  Serge Marbacher; Mika Niemelä; Juha Hernesniemi; Juhana Frösén
Journal:  Neurosurg Rev       Date:  2017-08-17       Impact factor: 3.042

3.  Predictors of intraoperative intracranial aneurysm rupture in patients with subarachnoid hemorrhage: a retrospective analysis.

Authors:  Maciej J Frączek; Miłosz J Błoński; Kornelia M Kliś; Roger M Krzyżewski; Jarosław Polak; Krzysztof Stachura; Borys M Kwinta
Journal:  Acta Neurol Belg       Date:  2022-06-27       Impact factor: 2.396

4.  Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique.

Authors:  Edin Nevzati; Jeannine Rey; Daniel Coluccia; Donato D'Alonzo; Basil Grüter; Luca Remonda; Javier Fandino; Serge Marbacher
Journal:  J Vis Exp       Date:  2017-10-01       Impact factor: 1.355

5.  Histopathological analysis of in vivo specimens of recurrent aneurysms after coil embolization.

Authors:  Chao Wang; Mengxing Li; Huiyuan Chen; Xinjian Yang; Ying Zhang; Dong Zhang
Journal:  J Neurointerv Surg       Date:  2021-10-21       Impact factor: 8.572

Review 6.  Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research.

Authors:  David M Sawyer; Peter S Amenta; Ricky Medel; Aaron S Dumont
Journal:  Mediators Inflamm       Date:  2015-04-01       Impact factor: 4.711

Review 7.  Preemptive Medicine for Cerebral Aneurysms.

Authors:  Tomohiro Aoki; Kazuhiko Nozaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-04-06       Impact factor: 1.742

8.  Preclinical extracranial aneurysm models for the study and treatment of brain aneurysms: A systematic review.

Authors:  Serge Marbacher; Fabio Strange; Juhana Frösén; Javier Fandino
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-03       Impact factor: 6.200

Review 9.  Bioactive refinement for endosaccular treatment of intracranial aneurysms.

Authors:  Zoltan Szatmary; Jérémy Mounier; Kevin Janot; Jonathan Cortese; Claude Couquet; Frédéric Chaubet; Ramanathan Kadirvel; Sylvia M Bardet; Charbel Mounayer; Aymeric Rouchaud
Journal:  Neuroradiol J       Date:  2021-07-01

Review 10.  Biology of Saccular Cerebral Aneurysms: A Review of Current Understanding and Future Directions.

Authors:  Vernard S Fennell; M Yashar S Kalani; Gursant Atwal; Nikolay L Martirosyan; Robert F Spetzler
Journal:  Front Surg       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.